Technical Analysis for CKPT - Checkpoint Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 4.39 0.00% 0.00
CKPT closed unchanged on Thursday, September 20, 2018, on 1.53 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical CKPT trend table...

Date Alert Name Type % Chg
Sep 19 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Sep 18 Outside Day Range Expansion 3.54%
Sep 18 Down 3 Days in a Row Weakness 3.54%
Sep 17 Narrow Range Bar Range Contraction 1.39%
Sep 17 NR7 Range Contraction 1.39%
Sep 17 NR7-2 Range Contraction 1.39%
Sep 14 Calm After Storm Range Contraction -1.13%
Sep 14 NR7 Range Contraction -1.13%
Sep 13 180 Bullish Setup Bullish Swing Setup -3.52%
Sep 13 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.52%

Older signals for CKPT ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Checkpoint Therapeutics, Inc. is an immuno-oncology biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. The Company is engaged in developing a portfolio of human immuno-oncology targeted antibodies. The portfolio of antibodies that it licensed includes antibodies targeting programmed death-ligand 1 (PD-L1), glucocorticoid-induced Tumor necrosis factor receptor (TNFR) related protein (GITR) and carbonic anhydrase IX (CAIX). It focuses on developing the immuno-oncology and checkpoint inhibitor antibodies. It is developing three oral, small molecules, targeted anti-cancer agents, consisting of an inhibitor of epidermal growth factor receptor (EGFR) mutations, an inhibitor of the bromodomain and extra-terminal (BET) protein, BRD4, and an inhibitor of poly (ADP-ribose) polymerase (PARP). Its pipeline of products includes CK-101 and CK-103.
Is CKPT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.149
52 Week Low 2.22
Average Volume 126,537
200-Day Moving Average 3.793
50-Day Moving Average 3.5139
20-Day Moving Average 4.1985
10-Day Moving Average 4.346
Average True Range 0.4074
ADX 16.0
+DI 18.1185
-DI 17.2241
Chandelier Exit (Long, 3 ATRs ) 3.5278
Chandelier Exit (Short, 3 ATRs ) 4.8422
Upper Bollinger Band 4.7433
Lower Bollinger Band 3.6537
Percent B (%b) 0.68
BandWidth 25.952126
MACD Line 0.2304
MACD Signal Line 0.2633
MACD Histogram -0.0329
Fundamentals Value
Market Cap 111.37 Million
Num Shares 25.4 Million
EPS -1.10
Price-to-Earnings (P/E) Ratio -3.99
Price-to-Sales 75.20
Price-to-Book 6.30
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.95
Resistance 3 (R3) 4.95 4.78 4.85
Resistance 2 (R2) 4.78 4.64 4.77 4.82
Resistance 1 (R1) 4.58 4.55 4.50 4.58 4.79
Pivot Point 4.41 4.41 4.36 4.40 4.41
Support 1 (S1) 4.21 4.27 4.13 4.21 3.99
Support 2 (S2) 4.04 4.18 4.03 3.96
Support 3 (S3) 3.84 4.04 3.93
Support 4 (S4) 3.84